Global Synthetic Bone Graft Substitute Syringe Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Synthetic Bone Graft Substitute Syringe market size was valued at US$ 4032 million in 2024 and is forecast to a readjusted size of USD 6056 million by 2031 with a CAGR of 6.1% during review period.

A synthetic bone graft substitute syringe is a medical device used to inject synthetic bone or other bone substitutes to treat fractures, bone defects, and other conditions. It usually consists of a syringe body containing synthetic bone or other bone substitute and needle. When used, the doctor will insert the syringe needle into the patient"s fracture or bone defect site, and inject synthetic bone or other bone substitutes into the fracture or bone defect site through the syringe body to promote fracture healing and repair bone defects.

With the continuous development of biomaterial technology, more synthetic bone substitute materials with excellent properties will be available in the future. These materials will be closer to the properties of autogenous bone, have better biocompatibility and mechanical properties, and can better adapt to the treatment needs of different bone diseases.

This report is a detailed and comprehensive analysis for global Synthetic Bone Graft Substitute Syringe market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Synthetic Bone Graft Substitute Syringe market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Synthetic Bone Graft Substitute Syringe market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Synthetic Bone Graft Substitute Syringe market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Synthetic Bone Graft Substitute Syringe market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Synthetic Bone Graft Substitute Syringe

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Synthetic Bone Graft Substitute Syringe market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biomatlante, Nordson MEDICAL, TEKNIMED, DSI Dental Solutions, Augma Biomaterials, Citagenix, Collagen Matrix, Sunstar Americas, Inc., Osteogenics Biomedical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Synthetic Bone Graft Substitute Syringe market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Capacity: 0.5cc
Capacity: 1.0cc
Others

Market segment by Application
Hospital
Ambulatory Surgery Center
Others

Major players covered
Biomatlante
Nordson MEDICAL
TEKNIMED
DSI Dental Solutions
Augma Biomaterials
Citagenix
Collagen Matrix
Sunstar Americas, Inc.
Osteogenics Biomedical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Synthetic Bone Graft Substitute Syringe product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Synthetic Bone Graft Substitute Syringe, with price, sales quantity, revenue, and global market share of Synthetic Bone Graft Substitute Syringe from 2020 to 2025.

Chapter 3, the Synthetic Bone Graft Substitute Syringe competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Synthetic Bone Graft Substitute Syringe breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Synthetic Bone Graft Substitute Syringe market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Synthetic Bone Graft Substitute Syringe.

Chapter 14 and 15, to describe Synthetic Bone Graft Substitute Syringe sales channel, distributors, customers, research findings and conclusion.